Protara Therapeutics, Inc. (TARA) Form S-3 — May 13, 2026
Protara Therapeutics, Inc. has filed a shelf registration statement on Form S-3, allowing the company to offer up to $300,000,000 in various securities, including common stock, preferred stock, debt securities, and warrants. This registration statement replaces the prior registration statement (File No. 333-275290) and includes unsold securities with a maximum aggregate offering price of $110,914,137.87.
Key figures
- Total shelf capacity
- $300,000,000
- Unsold securities value
- $110,914,137.87
Price after filing
1 day: +1.9%7 days: -8.5%30 days: -29.8%
Close on the filing date to close N calendar days later (from $5.20). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.